← Back to Clinical Trials
Recruiting NCT06844981

NCT06844981 Effects of Latin Dancing on Sleep Quality in Hispanic Cancer Survivors

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06844981
Status Recruiting
Phase
Sponsor Rutgers, The State University of New Jersey
Condition Cancer Survivorship
Study Type INTERVENTIONAL
Enrollment 40 participants
Start Date 2026-04-01
Primary Completion 2026-12

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Latin Dance

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 40 participants in total. It began in 2026-04-01 with a primary completion date of 2026-12.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The primary objective is to assess the feasibility, acceptability and explore the impact of a culturally appropriate Latin Dance intervention vs. Usual Care on sleep quality for Hispanic cancer survivors. Secondary objectives are to examine the preliminary efficacy of a culturally appropriate Latin Dance intervention on secondary cancer- and treatment-related side effects (e.g., Quality of Life, distress, insomnia, fatigue).

Eligibility Criteria

Inclusion Criteria: * Be 18 years of age or older * Self-identify as Hispanic and/or Latino(a) * Have a confirmed diagnosis of a solid tumor or hematologic malignancy * Must have completed primary cancer treatment 3+ months prior to enrollment (e.g., chemotherapy, surgery, and/or radiation therapy but may be on hormonal therapy and/or immunotherapy or other long-term therapies) * Have sleep disturbance (indicated by a response of 3 or more on the MD Anderson Symptom Inventory sleep question by using an 11-point scale anchored by 0 \[no sleep disturbance\] and 10 \[worst possible sleep disturbance\] * Be able to read and understand English and/or Spanish * Physically Inactive (\<150 minutes of vigorous exercise/week within the past 3 months) Exclusion Criteria: * Current regular Latin dancing practice within the past year (2-3 times a week over a period of two months that is not interrupted). * Inability to speak and read English or Spanish proficiently * Inability to understand informed consent * Medical conditions that can cause sleep impairment: sleep apnea, restless leg syndrome, shift work * Regular use of a walker or wheelchair * Healing or unhealed fractures * Heart failure * Life expectancy \<12 months * Unwilling to be randomized to study arms and/or commit to 8 weeks of classes and a follow-up assessment

Contact & Investigator

Central Contact

Evelyn Arana, DrPH

✉ earana@CINJ.Rutgers.edu

📞 908-642-0861

Principal Investigator

Evelyn Arana, DrPH

PRINCIPAL INVESTIGATOR

Rutgers Cancer Institute

Frequently Asked Questions

Who can join the NCT06844981 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Cancer Survivorship. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06844981 currently recruiting?

Yes, NCT06844981 is actively recruiting participants. Contact the research team at earana@CINJ.Rutgers.edu for enrollment information.

Where is the NCT06844981 trial being conducted?

This trial is being conducted at New Brunswick, United States.

Who is sponsoring the NCT06844981 clinical trial?

NCT06844981 is sponsored by Rutgers, The State University of New Jersey. The principal investigator is Evelyn Arana, DrPH at Rutgers Cancer Institute. The trial plans to enroll 40 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology